17-phenyl-18,19,20-trinorprostaglandin F2 alpha,
38344-08-0,
17-phenyl-trinor-PGF2alpha,
UNII-2683MK55HG,
17-PHENYLTRINORPROSTAGLANDINF2ALPHA,
CHEMBL3914661,
2683MK55HG,
17-Phenyl trinor prostaglandin F2alpha,
17-phenyl-trinor-Prostaglandin F2alpha,
9S,11R,15S-trihydroxy-17-phenyl-18,19,20-trinor-5Z,13E-prostadienoic acid,
Bimatoprost Acid,
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid,
bimatoprost (free acid form),
C23H32O5,
17-phenyl-omega-trinor-PGF2alpha,
(5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)hept-5-enoic acid,
(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(S,E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid,
AC1NR1HD,
17-Phenyl-18,19,20-trinorprostaglandin F2alpha,
GTPL1959,
SCHEMBL2472056,
CHEBI:73773,
FA(23:5)(OH3,cyclo2),
YFHHIZGZVLHBQZ-KDACTHKWSA-N,
(Z)-7-[(1R,2R,3S,5S)-3,5-dihydroxy-2-[(E)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]hept-5-enoic acid,
1272AH,
BDBM50206014,
LMFA03010081,
ZINC13589949,
AC-30204,
U-35687,
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}hept-5-enoic acid,
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-, (1R-(1alpha(Z),2beta(1E,3S*),3alpha,5alpha))-,
D08QWQ,
Cid 6441592,
ACN-041395,
C23-H32-O5,
CID5283081,
(5Z)-7-[(1R)-3alpha,5alpha-Dihydroxy-2beta-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentan-1alpha-yl]-5-heptenoic acid,
(5Z)-7-{(1R,2R,3S,5S)-3,5-dihydroxy-2-[(1E)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}hept-5-enoic acid,